Radiating Amyloid Fibril Formation on the Surface of Lipid Membranes through Unit-Assembly of Oligomeric Species of α-Synuclein

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Lee, Jung Ho ^a   Hong, Chul Suk ^a   Lee, Soonkoo ^a   Yang, Jee Eun ^a   Park, Yong Il ^a   Lee, Daekyun ^a   Hyeon, Taeghwan ^a   Jung, Seunho ^b   Paik, Seung R ^a  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; LIPID; OLIGOMER; RADIATING AMYLOID FIBRIL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED STUDY; LIPID MEMBRANE; LYSOSOME; MEMBRANE BIOLOGY; MEMBRANE DAMAGE; MEMBRANE STRUCTURE; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN ASSEMBLY; PROTEIN LIPID INTERACTION; SURFACE PROPERTY;

ALPHA-SYNUCLEIN; AMYLOID; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; LEWY BODIES; LIPIDS; LYSOSOMES; MEMBRANES; MITOCHONDRIA; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 84867525379     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047580     Document Type: Article

References (26)

1. Chiti F, Dobson CM, (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333-366.
2. Ross CA, Poirier MA, (2004) Protein aggregation and neurodegenerative disease. Nat Med 10: S10-S17.
3. Hardy J, Selkoe DJ, (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297: 353-356.
4. Lee J-H, Bhak G, Lee S-G, Paik SR, (2008) Instantaneous amyloid fibril formation of α-synuclein from the oligomeric granular structures in the presence of hexane. Biophys J 95: L16-L18.
5. Bhak G, Lee J-H, Hahn J-S, Paik SR, (2009) Granular assembly of α-synuclein leading to the accelerated amyloid fibril formation with shear stress. PLoS ONE 4: e4177.
6. Lee D, Choe Y-J, Choi YS, Bhak G, Lee J, et al. (2011) Photoconductivity of pea-pod-type chains of gold nanoparticles encapsulated within dielectric amyloid protein nanofibrils of α-synuclein. Angew Chem Int Ed Engl 50: 1332-1337.
7. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, et al. (1997) α-synuclein in Lewy bodies. Nature 388: 839-840.
8. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M, (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95: 6469-6473.
9. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, et al. (2000) Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders. Science 287: 1265-1269.
10. Gai WP, Yuan HX, Li XQ, Power JTH, Blumbergs PC, et al. (2000) In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neur, N Y 166: 324-333.
11. Bhak G, Choe Y-J, Paik SR, (2009) Mechanism of amyloidogenesis: Nucleation-dependent fibrillation versus double-concerted fibrillation. BMB Rep 42: 541-551.
12. Forno LS, (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55: 259-272.
13. Roy S, Wolman L, (1969) Ultrastructural observations in Parkinsonism. J Pathol 99: 39-44.
14. Hasegawa M, Fujiwara H, Nonaka T, (2002) Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions. J Biol Chem 277: 49071-49076.
15. Giasson BI, Duda JE, Murray IVJ, Chen Q, Souza JM, et al. (2000) Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science 290: 985.
16. McNaught KSP, Olanow W, (2006) Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease. Neurobiol Aging 27: 530-545.
17. Shults CW, (2006) Lewy bodies. Proc Natl Acad Sci USA 106: 1661-1668.
18. Reynolds NP, Soragni A, Rabe M, Verdes D, Liverani E, et al. (2011) Mechanism of membrane interaction and disruption by α-synuclein. J Am Chem Soc133: 19366-19375.
19. Varkey J, Isas JM, Mizuno N, Jensen MB, Bhatia VK, et al. (2010) Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins. J Biol Chem 285: 32486-32493.
20. Conway KA, Lee S-J, Rochet J-C, Ding TT, Williamson RE, et al. (2000) Acceleration of oligomerization, not fibrillation, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc Natl Acad Sci USA 97: 571-576.
21. Goldberg MS, Lansbury PT, (2000) Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? Nat Cell Biol 2: E115-E119.
22. Huang X, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JDA, et al. (1999) Cu(II) potentiation of Alzheimer Aβ neurotoxicity. J Biol Chem 274: 37111-37116.
23. Bush AI, Tanzi RE, (2002) The galvanization of β-amyloid in Alzheimer's disease. Proc Natl Acad Sci USA 99: 7317-7319.
24. Paik SR, Lee J-H, Kim D-H, Chang C-S, Kim J, (1997) Aluminum-Induced Structural Alterations of the Precursor of the Non-Aβ Component of Alzheimer's Disease Amyloid Arch Biochem Biophys. 344: 325-334.
25. Park J, An K, Hwang Y, Park J-G, Noh H-J, et al. (2004) Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 3: 891-895.
26. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, et al. (2002) In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298: 1759-1762.